{"id":"57f890f7-8f37-4a48-af71-4e79bf65f4f8","kind":"institutions","code":"UB-I3373","name":"Novartis Pharma","nameBasis":"original-brand","summary":"Novartis Pharma, a U.S. corporate strategic investor investing corporate capital in growth-stage and mature companies.","description":"Novartis Pharma, a U.S. corporate strategic investor investing corporate capital in growth-stage and mature companies.","country":null,"category":null,"originalName":"Novartis Pharma","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:56:23.941Z","englishUpdatedAt":"2026-10-15T17:35:39.039Z","reviewedAt":"2026-10-15T17:35:39.039Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e783f7052066c742ba9ddccb88006c8c033ed4046d622c4edffb1d2c5938415a","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"Novartis Pharma，美国企业开展战略投资的投资主体，以产业资本布局成长期与成熟期企业。","sources":[],"related":[{"id":"2f307ff8-f67b-4364-9f88-97d8a621773d","kind":"news","code":"2f307ff8-f67b-4364-9f88-97d8a621773d","name":"Alto Neuroscience raises USD 35 million in Series B financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Alto Neuroscience完成3500万美元B轮融资","eventDate":"2022-11-01T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T10:58:17.826Z","englishUpdatedAt":"2026-10-15T17:19:59.363Z","reviewedAt":"2026-10-15T17:19:59.363Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"c00e667f0999b63f48b9dc44771bb69ab3c724877fb2c31b9f75c2b86e149e0e","companyId":"c1d4c299-de74-4254-970a-ee70900d621b","foundedYear":null,"logoUrl":null,"path":"/news/2f307ff8-f67b-4364-9f88-97d8a621773d"}],"path":"/institutions/novartis-pharma","structured":{"city":null,"country":"United States","location":null,"role":null,"category":null,"company":null},"definition":"Novartis Pharma is a strategic investor based in the United States with 1 recorded investment.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/novartis-pharma"}